Comparative Analysis of Data Trends in Suppl. Figure 2

Feb 13, 2025

10 likes | 83 Views

This study provides a detailed comparison and analysis of the trends observed in the supplementary Figure 2 data, offering valuable insights and implications for further research and decision-making.

Share Presentation

Embed Code

richard-gibbs

Download Presentation

Comparative Analysis of Data Trends in Suppl. Figure 2

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Suppl. Figure 2

Suppl Figure 1.

Suppl Figure 1. . Supplementary figure S1: Dose-response curves BL: baseline measurement; H/N: measurement after randomisation to hypoxia or normoxia . Open symbols represent normoxic rats, closed symbols are hypoxic rats.

183 views • 6 slides

Suppl. Figure 1

Suppl. Figure 1. ( ng /ml). IL-6 in cell supernatant. IL-6 in animal serum. *. *. *. *. CV IL6SV CV IL6SV. CV IL6SV CV IL6SV. TRAMP-C1. TRAMP-HR. TRAMP-HR. TRAMP-C1. Suppl. Figure 2. IHC CD31. IHC Ki-67. TRAMP-C1. TRAMP-HR.

168 views • 2 slides

Suppl. Figure 4

A. DMSO. DMH1. 10 4. 14% of CD56 hi. 7% of CD56 hi. 10 3. CD56. 10 2. 7 % of CD56 Int. 3% of CD56 Int. 10 1. 0. 0. 10 1. 10 2. 10 3. 10 4. IFN- . B. IL-2. 20 ng /ml. 5 0 ng /ml. Only. + 20  M DMH1. 0. 10 1. 10 2. 10 3. 10 4. CFSE. C. IL-15.

99 views • 1 slides

Suppl. Figure 3

A. NKG2D. IL-2 + IL-12 +/- Dorsomorphin (  M). 100. 80. 60. % Max. 0. 1. 40. 20. 2. 5. 0. 10 0. 10 1. 10 2. 10 3. 10 4. 100. DMSO C ontrol. 80. 60. % Max. 40. 20. 0. 10 0. 10 1. 10 2. 10 3. 10 4. B. IL-2 + IL-12. + DMSO. (  M). + Dorsomorphin.

152 views • 1 slides

SUPPL FIGURE 1

SUPPL FIGURE 1. SUPPL FIGURE 2. A. B. --. Cal-A. LY294002. SUPPL FIGURE 3. CGP. CGP + ZNT. CGP + ZNT + ROL. A. B. SUPPL FIGURE 4. A. B. EXT. CAVEOLA. CAVEOLA. INT. G α s. G α s. G α i. G α s. . . β 2. β 2. β 2. β 2. P. P. P. P. AC. AC. AC. AC. . P. I-1.

180 views • 4 slides

Suppl. Figure 1

Suppl. Figure 1.

117 views • 1 slides

Suppl . Figure 1

Suppl . Figure 1. A. B.

120 views • 1 slides

Suppl Figure 4

500. 500. 500. 500. 400. 400. 400. 400. 300. 300. 300. 300. 200. 200. 200. 200. 100. 100. 100. 100. 0. 0. 0. 0. 0. 0. 0. 0. 200. 200. 200. 200. 400. 400. 400. 400. 600. 600. 600. 600. 800. 800. 800. 800. 500. 400. 300. 200. 100. 0. a. b. 20.

113 views • 1 slides

Suppl Figure 1

Suppl Figure 1. Growth characteristics of CHO-K1 wt and CKiD cells:

185 views • 3 slides

Suppl Figure 1

250. 200. 150. 100. 50. 0. Th0. Th1. Th2. Liver. Th17-2. Th17-1. Th17-3. Tbet. 400. GATA3. 300. 200. 400. 100. 300. 0. 200. 100. 0. Suppl Figure 1. a. b. c. AhR. FoxP3. AhR. 1000. 15. mRNA level to HPRT (x10 -3 ). mRNA level to HPRT (x10 -3 ).

131 views • 1 slides

Suppl. figure 2

Suppl. figure 2. A. B. C. D. E. F. G. H. I. J. K. L.

115 views • 1 slides

Suppl Figure 2

IL-22. 20. 18. 100. 16. 90. 14. 80. 12. 70. 10. 60. 8. 50. 6. 40. 4. 30. 2. 20. 0. 10. 0. a. IL-22. IL-17A. IL-17F. mRNA level to HPRT (x10 -3 ). 200. 20000. 70000. 150. 15000. 50000. 100. 10000. 30000. 50. 5000. 10000. 0. 0. 0. 0. 1. 1. 100. 100.

139 views • 1 slides

Suppl. Figure 1:

Suppl. Figure 1:. A. B. 31.9%.

89 views • 1 slides

Suppl. Figure 4

WT. ap2c1. AP2C1-oe. Suppl. Figure 4: Effect of AP2C1 on disease resistance Representative pictures show necroses on leaves of WT, ap2c1 and AP2C1-oe plants (line #640.2) infected with B. cinerea mycelium applied on agar plugs 4 days post inoculation. Suppl. Figure 4.

98 views • 1 slides

Suppl. Figure 2

Infect TIVE with BCBL-1 virus. TIVE KSHV + day 7 Ad-orf50 day 4. SLK KSHV + Ad-orf50. TIVE KSHV + day 7. TIVE KSHV -. 4 days post Inf. LANA IFA. K8.1. Induce lytic cycle TPA 6 days. Purify virus from TIVE; infect fresh TIVE cells. LANA IFA 4 days post Inf. Repeat 3 times.

123 views • 1 slides

Suppl Figure 5

Suppl Figure 5. WT ctl1. WT ctl1. conditional defect. NO 3 - , Cl - , sucrose Hermans et al . (2010). Low, moderate NO 3 -. High NO 3 -. Endogenous content/production ABA ↓ C K ↑ C 2 H 4 ↑↑ Exogenous supply ABA induces the arm phenotype

154 views • 1 slides

Suppl. Figure 1

Suppl. Figure 1. A. C. B. SLD. SPD. RLD. RPD. 5988. 1694. 94. 387. 64. 194.

130 views • 1 slides

Suppl. Figure 2

A. Isotype. 48 hr. 0 hr. CD56 Hi MFI:45. CD56 Hi MFI:20. CD56 High MFI:6. CD56. CD56 Int MFI:36. CD56 Int MFI:18. CD56 Int MFI:5. Intracellular BMPR1A. IL-2 + IL- 12 + Poly I:C. B. Isotype. IL-2. 10 4. CD56 Hi MFI:181. CD56 Hi MFI:19. CD56 Hii MFI:5. 10 4. 10 3.

138 views • 1 slides

Suppl. Figure 4

Suppl. Figure 4. K562. OSPC-2. 37.5 %. a). OSPC-2. K562. 1.45 %. FL4-H: scFvH6-Alexa647. FL4-H: scFvH6-Alexa647. b). A10-CLIP. A10-HALO.

154 views • 1 slides

Suppl. Figure 2

Suppl. Figure 2.

92 views • 1 slides

Suppl. Figure 3

Suppl. Figure 3.

85 views • 1 slides

Suppl Figure 5

Suppl Figure 5. MB947. MB1337. MB1547. Immunoblot of Effector Proteins in Tumors from PDTX Mice Treated with TAK-733. TAK-733. vehicle. S6. vehicle. vehicle. TAK-733. TAK-733. pS6. AKT. pAKT. ERK. pERK 1/2. α-tubulin. S. TGI Response. R. S. WT. BRAF Status. V600E. V600E.

120 views • 1 slides

More Related